Verastem Profit Margin

Verastem (VSTM) currently reports a profit margin of -231.59% as of June 2026. That compares with 2124.7% in the prior-year period — down 110.9% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Verastem's profit margin history and peer comparisons.

Verastem's profit margin decreased from 2124.7% to -231.59% — a 110.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Verastem's profit margin of -231.59% is lower than the Healthcare sector average of 13.89%. That is roughly 1766.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Verastem's current -231.59% should be judged against Healthcare norms (sector average: 13.89%) and against VSTM's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -231.59%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Verastem, and consider following VSTM for alerts when major investors trade the stock.